NCT07228273: Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
- State
- Under way
- Phase
- Phase 2
- People
- 102 planned
- Started
- 12 Dec 2025
- Primary completion
- 24 Jun 2029
- Arms
- Arm 1 (fludarabine, cytarabine, idarubicin, venetoclax)
- Results
- None posted
- 14 Nov 2025: Trial registered
- 12 Dec 2025: Trial started